Kymera Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Kymera Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2019 to Q3 2024.
  • Kymera Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 64.7M shares, a 16.8% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 64.7M +9.3M +16.8% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 61.6M +6.18M +11.2% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 61.4M +6.08M +11% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 55.4M +351K +0.64% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 55.5M +699K +1.28% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 55.4M +3.53M +6.81% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 55.3M +3.56M +6.88% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 55M +3.47M +6.72% Dec 31, 2022 10-K 2024-02-22
Q3 2022 54.8M +3.44M +6.7% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 51.9M +6.46M +14.2% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 51.7M +6.75M +15% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 51.6M +6.98M +15.7% Dec 31, 2021 10-K 2023-02-23
Q3 2021 51.3M +6.73M +15.1% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 45.4M Jun 30, 2021 10-Q 2021-08-06
Q1 2021 45M Mar 31, 2021 10-Q 2021-05-06
Q4 2020 44.6M +42.4M +1919% Dec 31, 2020 10-K 2022-02-24
Q3 2020 44.6M Sep 30, 2020 10-Q 2020-11-05
Q4 2019 2.21M Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.